Crossmark

Safety and Efficacy of Bendamustine and Rituximab (BR) Regimen in Indian Chronic Lymphocytic Leukaemia Patients

Published Online: 2022-05-27

Published Print: 2023-01

Authors

Gogia, Ajay

Gupta, Ritu

Sharma, Atul

kumar, Lalit

rani, Lata

Mallick, Saumyaranjan
License Information

Text and Data Mining valid from 2022-05-27

Version of Record valid from 2022-05-27
More Information

Article History

Received: 7 February 2022

Accepted: 19 April 2022

First Online: 27 May 2022

Declarations

:

: The authors have no conflict of interest to disclose.

Document is current